Team:Alberta-North-RBI E/FinanceHurdleBus

From 2012e.igem.org

(Difference between revisions)
(Finance-related)
 
(12 intermediate revisions not shown)
Line 1: Line 1:
{{UalbertaHeader3}}
{{UalbertaHeader3}}
 +
 +
 +
<html>
 +
<style type="text/css">
 +
 +
#toc, .toc {
 +
display: none
 +
}
 +
 +
</style>
 +
</html>
==Potential Hurdles==
==Potential Hurdles==
Line 5: Line 16:
===Finance-related===
===Finance-related===
-
As many start-ups, Upcycled Aromatics will require a significant amount of cash investment in its initial phase. In order to diminish this requirement, in addition to the traditional means of financing (angels, VC's, etc.), we will approach our feed suppliers (paper recycling plants) with an innovative plan: Front end payment for the installation of our technology for 3 years at a cost lower than the equivalent cost of their waste removal (estimated at $3000 per day for our first partner). This will allow us to secure capital early on in the development of the company. This will help us face the challenge of securing funding without excessively diluting our ownership of the company.
+
As many start-ups, '''Upcycled Aromatics''' will require a significant amount of cash investment in its initial phase. In order to diminish this requirement, in addition to the traditional means of financing (angels, VC's, etc.), we will approach our feed suppliers (paper recycling plants) with an innovative plan: Front end payment for the installation of our technology for 3 years at a cost lower than the equivalent cost of their waste removal (estimated at $3000 per day for our first partner). This will allow us to secure capital early on in the development of the company. This will help us face the challenge of securing funding without excessively diluting our ownership of the company.
Line 13: Line 24:
<html>
<html>
-
<center>
 
<p>
<p>
-Crowdsourcing (ie. Kickstarter)
-Crowdsourcing (ie. Kickstarter)
Line 26: Line 36:
<p>
<p>
-Upfront payment by feedstock suppliers <p>
-Upfront payment by feedstock suppliers <p>
-
</center>
+
 
</html>
</html>
-
RISK
+
===Regulatory policy===
-
Strain development
+
Since some of the potential buyers of the shikimic acid and cinnamic acid are pharmaceutical companies, we may meet the problem that our product cannot get approval from regulators ( e.g FDA).
-
It refers to the potential situation in which we encounter a problem in developing the process
+
 
-
Mitigation
+
 
-
We will develop our strain on proven technology, patents and use computer to simulate the whole process to make sure it is feasible
+
In order to mitigate this possibility, we plan to market our product to companies in a variety of industries including the pesticide industry, chemical industry, etc.
 +
 
 +
===Price volatility of the product===
 +
The price of our products will change with the fluctuations of market demand, and in some cases the price may be so low that we cannot sustain daily operations.
-
Feedstock quality
 
-
This refers to the potential problem that the fiber of the paper is too short to do further process or it is of poor quality
 
-
Mitigation
 
-
1. We should perform quality assessments on the feedstock
 
-
2. Proper enzymes should be selected for the different feedstocks
 
-
3. Some pretreatment to feedstock may be required prior to further processing
 
-
Intellectual property
 
-
Since shikimic acid production process has been patented, we cannot directly use the existing process to do shikimic acid production
 
-
Mitigation
 
-
We will design a process around the shikimic acid production and patent it
 
-
Regulatory policy
+
Having the ability to produce a variety of products means we are not at the mercy of one chemical's price. By shifting production to emphasize whichever chemicals are most profitable at a given time, we can adapt to variable market conditions.  If necessary, we will eliminate unnecessary costs such as trade shows and advertisements.
-
Since the potential buyers of the shikimic acid and cinnamic acid are pharmaceutical companies, we may meet the problem that our product cannot get approval from regulators ( e.g FDA)
+
-
Mitigation
+
-
Our product can be sent to various industries, such as the pesticide industry, the chemical industry, etc.
+
-
Price volatility of the product
+
===Competitive market===
-
The Price of the product will change with the fluctuations of market demand, and sometimes the price will be so low that we cannot sustain daily operations
+
Since the Shikimic market is controlled by Roche, we may encounter a strong entry barrier.
-
Mitigation
+
-
1. We will maintain the quality of the product
+
-
2. We should temporarily eliminate unnecessary costs such as trade shows and advertisements
+
-
Competitive market
 
-
Since the Shikimic market is controlled by Roche, we may encounter a strong entry barrier
 
-
Mitigation
 
-
We can seek out customers who need cheap Shikimic acid, also we eat away at Roche’s profits when a bad harvest of Chinese star anise occurs
 
-
   
+
We can counter this effect by seeking out customers who need cheap Shikimic acid. In addition, we may gain significant market share if we are able to supply Shikimic acid at a time when Roche is limited by a bad Chinese star anise harvest.  
{{UalbertaFooter}}
{{UalbertaFooter}}

Latest revision as of 18:21, 27 October 2012


Contents

Potential Hurdles

Finance-related

As many start-ups, Upcycled Aromatics will require a significant amount of cash investment in its initial phase. In order to diminish this requirement, in addition to the traditional means of financing (angels, VC's, etc.), we will approach our feed suppliers (paper recycling plants) with an innovative plan: Front end payment for the installation of our technology for 3 years at a cost lower than the equivalent cost of their waste removal (estimated at $3000 per day for our first partner). This will allow us to secure capital early on in the development of the company. This will help us face the challenge of securing funding without excessively diluting our ownership of the company.


For the early investment, it is a well known generality that new investors will evaluate a company's worth as much lower than the worth perceived by pre-existing investors. As a consequence, these pre-existing investors feel they are giving away too large a share of the company in exchange for the cash investment. In order to avoid this scenario, we are exploring a variety non-diluting funding options:


-Crowdsourcing (ie. Kickstarter)

-Licensing our technology in exchange for a cash payment

-Venture debt (Loan with fixed term and high interest rate)

-Convertible debt (Venture debt with option to convert to equity)

-Royalty financing (Cash payment in exchange for percentage of future profit)

-Upfront payment by feedstock suppliers

Regulatory policy

Since some of the potential buyers of the shikimic acid and cinnamic acid are pharmaceutical companies, we may meet the problem that our product cannot get approval from regulators ( e.g FDA).


In order to mitigate this possibility, we plan to market our product to companies in a variety of industries including the pesticide industry, chemical industry, etc.

Price volatility of the product

The price of our products will change with the fluctuations of market demand, and in some cases the price may be so low that we cannot sustain daily operations.


Having the ability to produce a variety of products means we are not at the mercy of one chemical's price. By shifting production to emphasize whichever chemicals are most profitable at a given time, we can adapt to variable market conditions. If necessary, we will eliminate unnecessary costs such as trade shows and advertisements.

Competitive market

Since the Shikimic market is controlled by Roche, we may encounter a strong entry barrier.


We can counter this effect by seeking out customers who need cheap Shikimic acid. In addition, we may gain significant market share if we are able to supply Shikimic acid at a time when Roche is limited by a bad Chinese star anise harvest.



Follow Us

Contact Us

Email: ualbertaigem@gmail.com

Search